Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer cases. EGFR is involved in several cancer developments, including NSCLC. The EGFR pathway regulates the Bax/Bcl-2 cascade in NSCLC. Increasing understanding of the molecular mechanisms of fundamental tumor progression has guided...
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English English |
| Vydáno: |
Frontiers Media SA
2022
|
| Témata: | |
| On-line přístup: | https://eprints.ums.edu.my/id/eprint/33339/1/Bax.pdf https://eprints.ums.edu.my/id/eprint/33339/2/Bax1.pdf |